About Casma Therapeutics
With deep expertise in cellular degradation biology, Casma is advancing targeted therapies for neurodegeneration and beyond.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Undisclosed
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
casmatx.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@CasmaTx
(421 followers)
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $46,000,000 · Series-B
casmatx.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Casma Therapeutics.
Funding History
Series-B equity
· Nov 15, 2022
$46,000,000 casmatx.com
Founders & Leadership
Andrea Ballabio
Founder & Scientific Advisor
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026